Reckitt Benckiser Group PLC Class Action Overview for Investors

Author: Caleb Price Updated: 07-28-2025 04:58 PM

Understanding the Class Action Lawsuit Against Reckitt Benckiser

Investors seeking to understand their legal options can start by looking into the class action lawsuit concerning Reckitt Benckiser Group PLC, a leading global consumer goods company. The lawsuit centers around allegations made against Reckitt Benckiser regarding their infant formula products.

Key Details of the Lawsuit

Why Are Investors Concerned?

The Portnoy Law Firm is advising investors of Reckitt Benckiser Group PLC (NASDAQ: RBGLY) regarding a class action lawsuit. This lawsuit concerns securities purchased during a specific timeframe from January 13, 2021, to July 28, 2024. Investors in Reckitt Benckiser have until August 4, 2025, to file a lead plaintiff motion to recover possible losses incurred during this period.

Legal Representation Available

For those affected, it's crucial to seek the advice of a legal professional. Investors are encouraged to reach out to attorney Lesley F. Portnoy, who offers complimentary case evaluations. Portnoy can be contacted by phone or email to discuss individual situations and rights to recover losses.

Allegations Made Against Reckitt Benckiser

The allegations state that during the class period, Reckitt Benckiser made misleading statements regarding the safety of their Enfamil infant formula. It is claimed that the company's cow's milk-based formula posed an increased risk of Necrotizing Enterocolitis (NEC) in preterm infants without sufficient warnings of these risks.

Impact of Recent Legal Proceedings

The timeline of events includes a significant verdict on March 15, 2024, when a jury found Mead Johnson negligent, awarding $60 million in damages for not alerting consumers to the dangers associated with their infant formula. Following the verdict, Reckitt Benckiser's shares dropped by nearly 14%, illustrating the substantial effects of these legal findings on investor confidence.

Subsequent Developments

Further complicating matters, on July 29, 2024, another jury in a related case awarded $495 million in damages linked to NEC risks associated with similar competing formulas. This outcome reportedly caused a nearly 9% decrease in Reckitt Benckiser's share price, further damaging investor standing.

Next Steps for Investors

Given the complex nature of legal proceedings and the potential for recovery of losses, investors should remain proactive. The option to engage in a class action could provide a necessary avenue for compensation. It's important for those affected by these events to stay informed about changes and updates in the lawsuit and about their individual rights.

Frequently Asked Questions

1. What is the class action lawsuit about?

The class action lawsuit involves allegations against Reckitt Benckiser concerning their Enfamil formula, specifically about the risks associated with its use in preterm infants.

2. How can I join the lawsuit?

Investors can join the lawsuit by contacting the Portnoy Law Firm for a consultation and guidance on filing a lead plaintiff motion before the deadline.

3. What are the potential outcomes of the lawsuit?

The potential outcomes include financial compensation for the investors who experienced losses during the class period due to the alleged misleading information from Reckitt Benckiser.

4. What do I need to prove in this lawsuit?

Investors will need to demonstrate that they suffered financial losses as a direct result of the misleading statements made by Reckitt Benckiser about their products.

5. Who should I contact for more information?

For more information, individuals are encouraged to reach out to attorney Lesley F. Portnoy at the Portnoy Law Firm for personalized legal advice and assistance.

About The Author

Hey there I'm Caleb Price, a writer and financial specialist who loves to assist others in understanding the financial world. Having years of practical experience and a solid background in finance, my area of expertise is converting difficult financial ideas into useful, doable insights for my blog and publications. My goal with my writing is to give readers the information and assurance they need to successfully negotiate their financial journeys.

My ability to interact with a wide range of people—from novices starting their investing journey to seasoned investors looking for new approaches—has come from contributing to several financial blogs. Making money approachable and understandable is my goal; this will enable you to make wise choices and realize your financial objectives. We appreciate you coming along on this path to success and financial empowerment on Investors Hangout.

Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.